Dana-Farber Cancer Institute and The Leukemia & Lymphoma Society bring Select Clinical Trials to Saint Francis Care

Learn more about the Saint Francis / Mount Sinai Regional Cancer Center...

(Hartford, Conn.  October 24, 2014) – Dana-Farber Cancer Institute, in collaboration with The Leukemia & Lymphoma Society (LLS), has established a network of community oncology practices bringing clinical trials testing innovative blood cancer therapies to community settings across the country, expanding blood cancer patients’ access to these clinical trials.

The newest community partner to join this consortium is Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Care. This groundbreaking Blood Cancer Research Partnership (BCRP) brings clinical trials closer to where patients live and helps to address one of the primary bottlenecks in the development of new cancer therapies: the need for more patients to take part in trials.

“It is a privilege for Saint Francis to be among just 11 sites nationally to offer patients access to Dana-Farber’s leading-edge clinical trials locally,” said Adam Boruchov, M.D., Hematology, Medical Oncology. “By bringing these trials to the greater Hartford area, more patients will benefit from the world-class research of the Dana-Farber Cancer Institute and LLS.” 

“This novel partnership between Dana-Farber Cancer Institute and LLS supports the mission of both organizations – to bring cutting-edge clinical research to a wider spectrum of patients with blood cancers today in order to change the paradigms of clinical care for patients tomorrow,” said Blood Cancer Research Program Co-Director Robert Soiffer, MD, who is the chief of the Division of Hematologic Malignancies at Dana-Farber. “The BCRP consortium provides the opportunity for the Division of Hematologic Malignancies to extend clinical research trials to patients who are outside our regional area and do not have the capacity to come to Dana-Farber.” 


There are three clinical trials currently open for accrual and are available to the consortium members. A number of additional clinical trial proposals are currently in development. Visit
http://www.dana-farber.org/bcrp for the latest information. 

“I believe this partnership provides a unique opportunity to deliver innovative clinical trials to patients closer to home,” says Blood Cancer Research Program Co-Director Irene Ghobrial, MD, who is a medical oncologist in the Division of Hematologic Malignancies at Dana-Farber. “It also creates a new pathway of collaboration between community oncologists, academic centers and foundations to improve cancer therapy for patients throughout the United States.” 

About Saint Francis Care 

Saint Francis Care is an integrated healthcare delivery system established by Saint Francis Hospital and Medical Center, an anchor institution in north central Connecticut since 1897.  Licensed for 617 beds and 65 bassinets, it is a major teaching hospital and the largest Catholic hospital in New England.  Other major entities of Saint Francis Care include The Mount Sinai Rehabilitation Hospital, the Connecticut Joint Replacement Institute, the Hoffman Heart and Vascular Institute of Connecticut, the Saint Francis/Mount Sinai Regional Cancer Center, the Joyce D. and Andrew J. Mandell Center for Comprehensive Multiple Sclerosis Care and Neuroscience Research, and Saint Francis HealthCare Partners.  Johnson Memorial Medical Center, parent organization of Johnson Memorial Hospital, Evergreen Health Care Center, and Home and Community Health Services is also a Saint Francis Care Partner.  Saint Francis Care’s services are supported by a network of five major Access Centers and eight additional medical office centers sited throughout the region.  For more information, visit www.stfranciscare.com. 

About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center, designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women’s Hospital as Dana-Farber/Brigham and Women’s Cancer Center and it provides pediatric care with Boston Children’s Hospital as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Facebook: www.facebook.com/danafarbercancerinstitute and on Twitter: @danafarber.
 

# # #